Top News

HOOKIPA reported positive preliminary Phase 2 data on HB-200 in combination with pembrolizumab in 1st-line setting for advanced head and...

The Ashley by LGI Homes at Stagecoach Station The Ashley includes an incredible open floor plan with a large dining...

– Received second IND application clearance for CABA-201 in myositis as well as Fast Track Designation in SLE and LN...

Record quarterly revenue of $485.2 million, including comparable restaurant sales growth of 10.5% Top-line strength helped deliver another quarter of improved...

Prominent sleep tech devices market players include Samsung Electronics, Fossil Group, Inc., Xiamoi Inc., Masimo, Fitbit Inc., Apple, Inc., Nihon...

Company reports second quarter 2023 XHANCE net revenue of $19.5 million and increases full year 2023 XHANCE net revenue guidance...

BOSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and...

Ninth patient dosed in ongoing Phase 1b trial evaluating tegoprubart in patients undergoing kidney transplantation; updated clinical data expected in...

SANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave Medical”) announced today that it...

Top-line 48-week results from the MOMENTUM Phase 2 obesity trial expected Q4 2023 Commenced enrollment in IMPACT Phase 2b trial...